Showing 34,870 results

HIV update - 26th April 2017

April 2017
PrEP

Thai HIV Advocates Drop the PrEP Ball

Editor's pick
AVAC
25 April 2017
Harm reduction

The Success of Italy’s Community-Based Approach to Naloxone

Editor's pick
Talking Drugs
25 April 2017
Hepatitis C symptoms & diagnosis

New Canadian guideline: No screening for hepatitis C in adults not at increased risk

Editor's pick
Eurekalert Inf Dis
25 April 2017
How HIV works

Pretreatment HIV, immune activation levels determine their persistence during treatment

Editor's pick
Eurekalert Inf Dis
25 April 2017
UK health services

Complexity of health system is 'holding back progress' in HIV care

Editor's pick
The King's Fund
25 April 2017
Access to healthcare

A quarter of people with second-line ART treatment failure in Kenya have exhausted current treatment options

News
25 April 2017

April 2017 (Issue 8)

April 2017
Hepatitis C treatment

Generic hepatitis C drugs continue to produce high cure rates

News
24 April 2017
Harm reduction

Canada is paving the way to import prescription heroin in bulk

Editor's pick
Vice
24 April 2017
Hepatitis B

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Editor's pick
EASL
24 April 2017
Global health initiatives

Three countries get first malaria vaccine

Editor's pick
BBC
24 April 2017
Harm reduction

Healing Austin, Indiana: How town raced to stop America's worst rural HIV plague (three-part series)

Editor's pick
Kentucky Courier-Journal
24 April 2017
PrEP

BHIVA response to The Irish Times article 'Anti-HIV drug removes personal responsibility'

Editor's pick
BHIVA
24 April 2017
Human rights

What women want – sexual and reproductive health rights

News
24 April 2017
Generic medicines

Switching from Atripla to generic-containing regimens can produce large cost savings

News
23 April 2017
Elimination of hepatitis C

New hepatitis data highlight need for urgent global response

Editor's pick
World Health Organization
21 April 2017
New & experimental hepatitis C treatment

AbbVie combination cures 95% of genotype 3 hepatitis C

News
21 April 2017
Access to healthcare

The Medicines Patent Pool and Pharco Pharmaceuticals Sign Licence for Promising Hepatitis C Drug Candidate Ravidasvir

Editor's pick
Medicines Patent Pool
21 April 2017
New & experimental hepatitis C treatment

New AbbVie hepatitis C combination cures 99% of people with cirrhosis

News
21 April 2017
Hepatitis C treatment

Direct-acting antivirals for hepatitis C not linked to higher liver cancer risk in most studies

News
21 April 2017
Hepatitis C treatment

European HCV treatment access survey shows big variations in eligibility

News
20 April 2017
Hepatitis C treatment

Curing hepatitis C reduces cardiovascular risk

News
20 April 2017
Pregnancy and vertical transmission

The living legacy of the Global Plan: eliminating HIV in children

Editor's pick
UNAIDS
20 April 2017